Dementia of the Alzheimer's type: changes in hippocampal L-[3H]glutamate binding.
about
An immunohistochemical study of GABA A receptor gamma subunits in Alzheimer's disease hippocampus: relationship to neurofibrillary tangle progressionInhibition of rabies virus infection in cultured rat cortical neurons by an N-methyl-D-aspartate noncompetitive antagonist, MK-801Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural NootropicThe glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer's diseaseSpermine modulation of the glutamate(NMDA) receptor is differentially responsive to conantokins in normal and Alzheimer's disease human cerebral cortex.Novel nootropic drug sunifiram enhances hippocampal synaptic efficacy via glycine-binding site of N-methyl-D-aspartate receptor.Molecular mechanisms of environmental enrichment: impairments in Akt/GSK3β, neurotrophin-3 and CREB signaling.Medicinal chemistry approaches for the treatment and prevention of Alzheimer's disease.Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer's disease.Proteolytic mechanism for the neurodegeneration of Alzheimer's disease.GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia.Hippocampal plasticity during the progression of Alzheimer's disease.Recent advances in the understanding of dementiaDifferential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.Rationale for combining glutamatergic and cholinergic approaches in the symptomatic treatment of Alzheimer's disease.Multiple excitatory amino acid receptor regulation of intracellular Ca2+. Implications for aging and Alzheimer's disease.Evidence of Abeta- and transgene-dependent defects in ERK-CREB signaling in Alzheimer's models.Parametric in vivo brain imaging during activation to examine pathological mechanisms of functional failure in Alzheimer disease.Apolipoprotein E, synaptic plasticity and Alzheimer's disease.Excitatory amino acid binding sites in the hippocampal region of Alzheimer's disease and other dementiasTowards a Better Understanding of GABAergic Remodeling in Alzheimer's Disease.Myelin basic protein is affected by reduced synthesis of myelin proteolipid protein in the jimpy mouse.Evaluation of multiple doses of milacemide in the treatment of senile dementia of the Alzheimer's type.Modulating the Balance of Synaptic and Extrasynaptic NMDA Receptors Shows Positive Effects against Amyloid-β-Induced Neurotoxicity.Characterization of perforant path lesions in rodent models of memory and attention.Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: hippocampus and cortex.Quantitative autoradiographic analysis of ionotropic glutamate receptor subtypes in human temporal lobe epilepsy: up-regulation in reorganized epileptogenic hippocampus.CaMKII activity is essential for improvement of memory-related behaviors by chronic rivastigmine treatment.Blockade of the KATP channel Kir6.2 by memantine represents a novel mechanism relevant to Alzheimer's disease therapy.Na(+)/K(+)-ATPase inhibition upregulates NMDA-evoked currents in rat hippocampal CA1 pyramidal neurons.Sigma-1 receptor stimulation by dehydroepiandrosterone ameliorates cognitive impairment through activation of CaM kinase II, protein kinase C and extracellular signal-regulated kinase in olfactory bulbectomized mice.Role of glutamate and glutamate receptors in memory function and Alzheimer's disease.NMDA receptor status in elderly normal individuals and those with Alzheimer's disease.
P2860
Q24613146-61596BEE-F79B-4AED-8E01-F0BC513F453FQ24645307-AC5C6DDA-AF3C-413F-8124-CAAD914E4837Q28071703-06899318-320C-4AC3-9E8F-6293862E6CD9Q28370052-3C4A1A56-50ED-4E2E-BB09-24E2A1783EE3Q34133434-BE1C0970-3BCF-4458-8D27-4C176EA9B2BDQ34348499-D2D0C049-3CEE-4E77-99A6-198FF85C35ECQ34735544-FA80F654-3A3C-4AD0-942D-49DD7C31DA17Q34993154-A15FB8A9-FC5D-43F1-AED6-4D0FEB7608D9Q35079696-5A1FD93C-05DC-4DB0-A64D-F8F9DFB5DC98Q35186159-D5E76DDE-A0C6-48A3-BEB4-32BC2C683264Q35884948-B35818CA-6213-4FF6-AC81-57E45FE1CD78Q36054541-83030962-04F8-4810-A1D3-29247F4D9D81Q36722253-7DC69D55-7F15-4C1F-ADB3-5B4471D87C23Q37695569-3E0B22BF-FAAA-40F8-92F0-D880D8449D08Q38066972-74C01F5C-BF66-4BC6-91BB-B1DCA3C6F72FQ38327323-7AB64733-CED2-4846-B96F-181FDE6638DFQ40087274-A214BE46-70E8-4D50-B35F-0BACA183A01FQ40701195-587E8407-E578-4650-BE90-E1B8CCAB1008Q40999874-7892CF1D-C6CE-4B28-BB11-5D0277C76BDBQ41200060-155CAE16-70B1-4A4A-8401-5B1504549C14Q41574564-ECCBDDA8-F91C-4675-96CB-F634FCA11B2BQ42794199-D8AF4DE3-3B9E-4398-8B07-8387988A3BAFQ46215532-F36D370D-F198-478F-B528-7AB427ED3F6BQ48275180-E3B859BA-16C5-40D2-8BC8-B2D2145C75F9Q48387009-3B8F14EF-DACA-441B-90E7-E7784938475EQ48545691-C34911B1-B71C-46FB-96A1-652D9E8771ADQ48569666-3ABDA3F4-9DF9-4ACD-B6E5-290188FDEAA8Q48909564-40EBF735-41FB-4A35-A868-E60CE294CC0AQ50482143-2526DF6C-B224-4C82-9889-F5CA451A0B08Q51011315-87DD345E-7377-4EF4-AA81-5E9024159E32Q51015549-53DE9DBD-DFC3-4E01-AFDD-79D029091ADBQ52053100-9DDDD7B8-FACB-4076-B8FF-C9DD427F54D2Q53207757-8A35BAF1-D005-40CD-9842-745A3E352A44
P2860
Dementia of the Alzheimer's type: changes in hippocampal L-[3H]glutamate binding.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh-hant
name
Dementia of the Alzheimer's type: changes in hippocampal L-[3H]glutamate binding.
@en
Dementia of the Alzheimer's type: changes in hippocampal L-[3H]glutamate binding.
@nl
type
label
Dementia of the Alzheimer's type: changes in hippocampal L-[3H]glutamate binding.
@en
Dementia of the Alzheimer's type: changes in hippocampal L-[3H]glutamate binding.
@nl
prefLabel
Dementia of the Alzheimer's type: changes in hippocampal L-[3H]glutamate binding.
@en
Dementia of the Alzheimer's type: changes in hippocampal L-[3H]glutamate binding.
@nl
P2093
P2860
P1476
Dementia of the Alzheimer's type: changes in hippocampal L-[3H]glutamate binding.
@en
P2093
D'Amato CJ
Greenamyre JT
P2860
P304
P356
10.1111/J.1471-4159.1987.TB04127.X
P407
P577
1987-02-01T00:00:00Z